Yunnan Baiyao GroupLtd Management
Management criteria checks 3/4
Yunnan Baiyao GroupLtd's CEO is Ming Dong, appointed in Mar 2021, has a tenure of 3.67 years. directly owns 0.001% of the company’s shares, worth CN¥786.01K. The average tenure of the management team and the board of directors is 2.6 years and 4.4 years respectively.
Key information
Ming Dong
Chief executive officer
CN¥4.3m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.7yrs |
| CEO ownership | 0.0007% |
| Management average tenure | 2.6yrs |
| Board average tenure | 4.4yrs |
Recent management updates
Recent updates
Calculating The Fair Value Of Yunnan Baiyao Group Co.,Ltd (SZSE:000538)
Oct 03
Yunnan Baiyao Group Co.,Ltd's (SZSE:000538) Business And Shares Still Trailing The Market
Sep 15Yunnan Baiyao GroupLtd (SZSE:000538) Could Easily Take On More Debt
Aug 06A Look At The Intrinsic Value Of Yunnan Baiyao Group Co.,Ltd (SZSE:000538)
Jun 30Earnings Working Against Yunnan Baiyao Group Co.,Ltd's (SZSE:000538) Share Price
Apr 21Yunnan Baiyao Group Co.,Ltd Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next
Apr 02Yunnan Baiyao Group Co.,Ltd (SZSE:000538) Shares Could Be 34% Above Their Intrinsic Value Estimate
Feb 27CEO
Ming Dong (48 yo)
3.7yrs
Tenure
CN¥4,251,000
Compensation
Mr. Ming Dong serves as Executive Director of Shanghai Pharmaceuticals Holding Co., Ltd since June 29, 2023. He serves as Chairman of the Board of YNBY International Limited (formerly known as Ban Loong Ho...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 3.7yrs | CN¥4.25m | 0.00074% CN¥ 786.0k | |
| Chief Financial Officer | 2.4yrs | CN¥1.84m | no data | |
| Chief Scientist | 2.8yrs | CN¥3.61m | no data | |
| Chief Compliance Officer & Senior VP | no data | CN¥2.76m | 0.0057% CN¥ 6.0m | |
| Chief Quality & Process Officer | no data | CN¥1.24m | no data | |
| Chief Innovation Officer | no data | CN¥3.64m | 0.028% CN¥ 30.0m | |
| Chief Commercial Officer & Senior VP | 1.7yrs | CN¥3.64m | no data | |
| Strategic Scientist of Chinese Medicine | no data | CN¥1.71m | no data | |
| Securities Representative | no data | no data | no data |
2.6yrs
Average Tenure
56.5yo
Average Age
Experienced Management: 000538's management team is considered experienced (2.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 2yrs | CN¥4.25m | 0.00074% CN¥ 786.0k | |
| Independent Director | 3.5yrs | CN¥257.10k | no data | |
| Independent Director | 5.3yrs | CN¥257.10k | no data | |
| Non-Independent Director | 2yrs | CN¥1.17m | no data | |
| Chairman of the Board | less than a year | no data | no data | |
| Independent Director | 5.3yrs | CN¥256.00k | no data | |
| Shareholder Representative Chairman of the Supervisory Board | 5.3yrs | no data | no data | |
| Shareholder Representative Vice Chairman of the Supervisory Board | 5.3yrs | no data | no data | |
| Non-Independent Director | 5.3yrs | no data | 0.70% CN¥ 745.8m | |
| Non-Independent Director | 5.3yrs | CN¥1.13m | 0.0099% CN¥ 10.6m | |
| Non-Independent Director | 2yrs | CN¥1.01m | no data | |
| Non-Independent Director | 2yrs | no data | no data |
4.4yrs
Average Tenure
55.5yo
Average Age
Experienced Board: 000538's board of directors are considered experienced (4.4 years average tenure).